Showing results (1-10 of 27) with videos related to
Sort By:
Pageof 3
European Journal of Ophthalmology|February 13, 2016
Visual and anatomic outcomes after conversion to aflibercept in neovascular age-related macular degeneration: 12-month resultsKaveh Abri Aghdam, Amelie Pielen, Carsten Framme, et al.Investigative Ophthalmology & Visual Science|October 8, 2015
Correlation Between Hyperreflective Foci and Clinical Outcomes in Neovascular Age-Related Macular Degeneration After Switching to AfliberceptKaveh Abri Aghdam, Amelie Pielen, Carsten Framme, et al.Ophthalmology|December 5, 2006
Retinal endovascular lysis in ischemic central retinal vein occlusion: one-year results of a pilot studyNicolas Feltgen, Bernd Junker, Hansjuergen Agostini, et al.Clinical Ophthalmology (Auckland, N.Z.)|October 14, 2017
Intraoperative optical coherence tomography and ab interno trabecular meshwork surgery with the TrabectomeBernd Junker, Jens F Jordan, Carsten Framme, et al.Acta Ophthalmologica|September 5, 2018
Optical coherence tomography angiography analysis of macular flow density in glaucomaRobert Kromer, Philipp Glusa, Carsten Framme, et al.Journal of the American Chemical Society|March 23, 2006
Asymmetric synthesis of highly substituted azapolycyclic compounds via 2-alkenyl sulfoximines: potential scaffolds for peptide mimeticsMichael Reggelin, Bernd Junker, Timo Heinrich, et al.Clinical Ophthalmology (Auckland, N.Z.)|April 21, 2020
Comparison of Macular Pigment Optical Density in Glaucoma Patients and Healthy Subjects - A Prospective Diagnostic StudyYannick Bruns, Bernd Junker, Daniel Boehringer, et al.Lasers in Surgery and Medicine|April 26, 2016
The short-term effects of aflibercept on the size of choroidal neovascularization lesion in treatment-resistant neovascular age-related macular degeneration as determined by spectral-domain optical coherence tomographyKaveh Abri Aghdam, Florian Seidensticker, Amelie Pielen, et al.Plos One|November 9, 2013
Efficacy and safety of intravitreal therapy in macular edema due to branch and central retinal vein occlusion: a systematic reviewAmelie Pielen, Nicolas Feltgen, Christin Isserstedt, et al.Therapeutic Advances in Endocrinology and Metabolism|December 20, 2019
How and why SGLT2 inhibitors should be explored as potential treatment option in diabetic retinopathy: clinical concept and methodologyMarcus May, Theodor Framke, Bernd Junker, et al.Pageof 3